CervoMed Inc.

US$1.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRVOHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (36.08%)
Div yield —
ROE (131.52%)
Biotechnology
Beta (5Y) (3.99)
PE TTM —
TSR TTM (79.86%)
Mkt cap US$21.48M
ROIC (84.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.58
10.99%
(34.79%)
Hold 11|3|6|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
34.50%
32.98%
22.78%
25.20%
Revenue$M
1.266
1.323
1.369
1.378
(5.56%)
(0.10%)
6.43%
10.05%
Peers (US$21.48M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.184
0.062
0.060
EBIT/Intx
0.866
0.289
0.295
Own earn%
(41.32)
7.79
15.42
Sh yield%
36.19
39.92
41.62
Owners
Insiders/Inst%
8.82
41.51
Short interest%
4.23
SBC / revenue%
0.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
25–31
$1 testx
—
Incr. ROIC%
3